Skip to content
OpenCapital
Get started

Bio-Rad Laboratories, Inc. BIO.B Life Science — Income from operations

Discontinued — last reported Q1 '23

Similar metrics at other companies

Revvity logo
RVTYLife Sciences — Segment operating income
$103.98M-1.6%
Revvity logo
RVTYLife Sciences — Reportable segment operating income (loss)
$102.98M-9.8%
STERIS logo
STELife Sciences: — Segment operating income
$61.8M+6.4%
Agilent Technologies logo
ALife Sciences and Diagnostics Markets — Income from operations
$161M+24.8%
PEA
PEAKLife Science — Income (loss) from continuing operations
——
PEA
PEAKLifescience — Profit Loss
——

Other financials

Income statement

See full
Revenue$592.1M+1.1%
Gross profit$309.4M+1.1%
Operating income$34.1M+43.9%
Net income-$527.1M-924%
EPS (diluted)-$19.55-954%

Balance sheet

See full
Cash & equivalents$509.0M-2.7%
Total debt$987.3M-28.4%
Total equity$6.9B+2.6%
Total assets$9.8B+2.8%

Cash flow

See full
Operating cash flow$108.1M-16.8%
CapEx$30.0M-12.8%
Free cash flow$78.1M-18.2%

Valuation

See full
Market cap$7.56B+10.3%
Enterprise value$8.04B+4.2%
P/E44.8×—
P/S2.9×+0.2×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin8.8%-3.1pp
Net margin6.5%+3.4pp
FCF margin13.8%-0.2pp

Returns & leverage

See full
Return on equity2.5%+1.3pp
Debt / equity0.1×-0.1×
Current ratio3.2×-2.8×

Where this comes from

Reported directly by Bio-Rad Laboratories, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Bio-Rad Laboratories, Inc.’s 10-Q, filed May 5, 2023, on SEC EDGAR. View the filing →

Ask your AI about Bio-Rad Laboratories, Inc.'s life science — income from operations.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bio-Rad Laboratories, Inc.'s life science — income from operations?
Bio-Rad Laboratories, Inc. (BIO.B) reported life science — income from operations of $35.7M in Q1 2023.
How has Bio-Rad Laboratories, Inc.'s life science — income from operations changed year-over-year?
Bio-Rad Laboratories, Inc.'s life science — income from operations decreased by 60.2% year-over-year, from $89.6M to $35.7M.
What does life science — income from operations mean?
The profit generated by the Life Science segment's day-to-day business operations.
How do you interpret life science — income from operations?
An increase indicates improved operational efficiency, higher sales volume, or better cost management within the segment.
How does life science — income from operations compare across companies?
The primary benchmark for comparing the operational performance of business units across different companies.